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SUMMARY
Introduction Klippel–Trénaunay syndrome (KTS) is a very rare congenital anomaly of blood vessels, 
characterized by the following clinical triad: varicose superficial veins, port-wine stain and usually 
bony and soft tissue hypertophy of extremities, most often located in the lower extremities. It is often 
accompanied by visceral manifestations, and rarely combined with splenomegaly.
Case Outline A 30-year-old female patient came to the Surgery Clinic because of occasional left 
hypochondrial pain. After she was diagnosed with KTS combined with splenomegaly, splenectomy was 
performed. Macroscopic and microscopic spleen examination indicated the presence of tumor of vascular 
origin, presenting a combination of lymphangioma and hemangioma.
Conclusion Diagnosed KTS demands a thorough clinical examination of the patient because of the 
potential presence of visceral manifestations. When splenomegaly is present, even though being often 
benign, splenectomy is usually performed to alleviate accompanying symptoms which occur as a result of 
organ enlargement and compression, to prevent rupture and consequential bleeding when the vascular 
spleen tumor is large, and finally to avoid a possibility of malignant transformation.
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INTRODUCTION
Klippel–Trénaunay syndrome (KTS) is a very 
rare congenital anomaly of blood vessels, char-
acterized by the following clinical triad: vari-
cose superficial veins, port wine stain and bony 
and/or soft tissue hypertrophy of extremities, 
usually unilateral and located in the lower ex-
tremities [1, 2]. Manifestation of the complete 
triad occurs in 63% of patients with KTS [3], 
but in order to diagnose its presence two signs 
are needed [4, 5]. This syndrome is sometimes 
associated with visceral vascular malforma-
tions which additionally make the patient’s 
general condition more complex. These mal-
formations usually include hemangiomas or 
lymphangiomas of the colon, small intestine, 
bladder, kidney, spleen, liver and central ner-
vous system [1, 3, 6, 7, 8]. Most frequent com-
plications are stasis dermatitis, coagulopathies, 
pulmonary embolism, heart failure, bleeding 
from altered blood vessels, mostly from the 
gastrointestinal and genitourinary tract. Mor-
tality rate in patients with KTS is about 1% [3].
We are presenting a case of a 30-year-old 
female patient diagnosed with KTS and as-
sociated splenomegaly due to the presence 
of a benign tumor of vascular origin, which 
according to histological characteristics, rep-
resents a combination of lymphangioma and 
hemangioma.
CASE REPORT
A 30-year-old female patient came to the Sur-
gery Clinic because of the occasional left hypo-
chondrial pain that lasted for several months. 
During the clinical inspection a giant hemangi-
oma was noticed on the left leg, mostly located 
on the thigh and to a less extent on the knee 
and lower leg area. The left leg was hypertro-
phic, deformed and shorter in comparison to 
the right one, which did not have any patho-
morphological changes (Figure 1). Enlarged 
spleen was detected by abdominal palpation, 
whereas physical findings of other body sys-
tems were normal. The patient was diagnosed 
with KTS.
There was no family history of any similar 
diseases among the closest relatives. Immedi-
ately after admission to the Clinic, necessary 
laboratory and diagnostic analyses were per-
formed. Cardiac and lung examination did not 
indicate any abnormalities. Magnetic resonance 
imaging of the abdomen showed an enormous-
ly enlarged multicystic spleen, of the largest 
diameter 123×101.8 mm, reaching the pelvic 
bones. Cysts in the spleen were up to 15 mm 
in diameter among which one was conspicuous 
with 11×10 cm in diameter, located in the upper 
part and filled with liquid material (Figure 2).
Laboratory analysis findings: red blood cells 
3.65×1012/l, hemoglobin 113 g/l, hematocrit   
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Figure 1. Depiction of the lower extremity of the patient, a giant hemangioma of the left leg, which is hypertrophic, shortened and deformed
Figure 2. Magnetic resonance imaging of the lien Figure 3. Histopathological finding of the spleen (hematoxylin and 
eosin staining, original magnification ×200)     
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0.337, white blood cells 4.7×109/l, platelets 160×109/l, 
aPTT 37.9 s, INR 1.267, fibrinogen 1.676 g/l. Due to the 
enormously enlarged spleen and accompanying symptoms, 
elective splenectomy was indicated. Laparatomy was per-
formed by opening the abdomen with a left subcostal inci-
sion and an intraoperatively enormously enlarged spleen, 
approximately 260 mm in diameter, was noticed. Splenec-
tomy was performed in the usual way, without any sig-
nificant bleeding during the intervention. Removed spleen 
was sent for pathohistological analysis. Macroscopically, 
removed spleen weighted 550 g, and was 260×150×65 mm 
in diameter, grey brown in color, with uneven surface. Tis-
sue sections showed a larger number of cystic spaces, sized 
from a few millimeters to several centimeters (the largest 
cavity was 11 cm in diameter), which were partially filled 
with blood and partially with a yellowish clear content. On 
the periphery of the multicystic mass, a zone of brown red 
spleen tissue was noticed. Microscopically, a tumor was 
detected in the spleen, which was composed of numerous 
dilated lymph and venous blood vessels, irregular in shape, 
consisting of either blood or eosinophil content and coated 
with flattened endothelial cells. The surrounding spleen 
tissue, apart from a mild degree of white pulp atrophy and 
hyaline degeneration of the blood vessel walls, did not in-
dicate any other histological changes. The diagnosis of 
benign tumor was passed, and the tumor was determined 
to be a combination of spleen lymphangioma and heman-
gioma (Figure 3). The postoperative course was normal, 
and the patient was discharged three weeks after surgery.
DISCUSSION
Klippel–Trénaunay syndrome (KTS) represents a combina-
tion of port wine stain, varicose veins and hypertrophy of 
bones and/or soft tissues. The syndrome was described for 
the first time by Klippel and Trénaunay in 1900 [9]. Frederic 
Parcs Weber described a similar triad in 1907, but accom-
panied by arterial/vein fistulas as primary pathology [10].
Although being very rare, KTS is described well in the 
literature. Analysis of the largest published series of 268 
patients has reported that port wine stains were present 
in 98%, pathomorphological vein changes in 72%, and 
extremity hypertrophy in 67% of patients [3]. Vein mal-
formations often involve agenesia, hypoplasia, persistent 
embryonic veins, valvular insufficiency and aneurysms.
Even though the etiology of this syndrome is unknown, 
there are more and more data about the connection with 
heterogeneous gene mutations [11]. Szilagyi et al. [12] not-
ed that the possible cause was an abnormal development of 
mesoderm causing the enlargement in size and vein num-
ber, which led to bone and soft tissue hypertrophy. This 
theory is supported by the opinion according to which 
mesodermal abnormality is actually a result of defect in 
vascular endothelial growth factor (VEGF) mediated by 
vascular remodeling [13]. Most of KTS cases are sporadic 
and congenital trend has not been confirmed yet, although 
cases within the same family have been recorded [14]. In 
the series of 114 patients, two families with congenital 
KTS have been recorded, as well as the phenomenon of 
family hemihypertrophy of lower extremities within the 
first degree relatives [15]. KTS manifests at birth or early 
childhood. In 75% of cases it manifests before the age of 
10 years, being equally frequent within both genders, re-
gardless of race [3, 13]. Our patient was diagnosed with 
KTS immediately after birth. Patients with this syndrome 
often have systematic manifestations as visceral vascular 
malformations. Most often they involve hemangiomas 
and/or lyphangiomas with the incidence of up to 56% in 
some series [16]. Skin malformations in KTS are mostly 
capillary hemangiomas. Skin capillary malformations are 
diffuse or mostly located on the hypertrophic extremity 
side. Lower extremities are affected in about 95% of cases 
[3, 13]. In the case of the patient we present, hypertro-
phy and hemangioma are located on the left leg. Depth of 
affected tissue also varies; changes can be limited to the 
skin only or can affect subcutaneous tissue, muscles and 
bones [8]. The spleen is rarely affected in patients with 
KTS, and can appear as splenomegaly, hemangioma and/
or lymphangioma of the spleen [2, 8]. In the case of our 
patient, splenomegaly was caused by a mixed tumor of 
vascular origin with characteristics of both hemangioma 
and lymphangioma. The available literature records only 
two cases of KTS with associated lymphangiohemangioma 
of the spleen [8, 17]. Data also indicate that this type of 
vascular malformations is often followed by disorders of 
hemostasis, especially in patients with coagulopathies [18, 
19]. A mild degree of disorder was noticed in our patient, 
and was successfully treated. The diagnosis of a visceral 
tumor mass of vascular origin is easily made. Percuta-
neous biopsy is not recommended due to high bleeding 
risk. Noninvasive visualization imaging methods as ultra-
sonography, computerized tomography, magnetic reso-
nance imaging and lymphoscintigraphy are sufficient and 
often used for diagnosis and evaluation of these changes. 
Both hemangiomas and lymphangiomas are slow-grow-
ing tumors. Although most of spleen tumors are benign, 
yet they are incomparably rarer than those located in the 
liver. They mainly cause symptomatology which occurs as 
a consequence of pressure on the surrounding structures. 
There is often undefined pain which can be seen from 
our presentation. Sometimes lymphangiomas are associ-
ated with lymphangiomatosis located in the mediastinum, 
retroperitoneum, axilla or neck, whereas KTS hemangio-
mas are often associated with generalized malformations 
of blood vessels. Lymphangiomas are rarely unilocular or 
more often, as in this case, made of numerous septated 
cystic areas [20]. Pathohistologically they are coated with 
a single row of flattened endothelium containing unstruc-
tured eosinophilic content in the lumen, with detached 
lymphocytes, in contrast to vascular hemangioma areas 
which consist of blood. Hemagiomas grow as a single tu-
mor or they occur in multiple areas, they can be localized 
or diffuse lesions, and histologically in a capillary or dif-
fuse form. Usually they are small (1-3 cm in diameter), 
rarely bigger in diameter, and sporadically enormous in 
size. Complications are spleen rapture, hypersplenism and 
malignant transformation [21].  
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It is difficult to predict the outcome of hemangiomas 
in solid organs. Prognosis is mostly good, but there is al-
ways a risk of rupture due to minor trauma. Changes in 
diameter larger than 4 cm indicate increased susceptibil-
ity to rupture (with incidence of 25%) and can lead to 
fatal bleeding [22, 23]. In adult patients ruptures or other 
complications have not been recorded due to monitoring 
and applied conservative methods. [24] Given that in our 
patient spleen hemangioma was larger than 4 cm and that 
she had symptoms such as pain in the left hypochondrium, 
splenectomy was absolutely indicated.
It should be kept in mind that in patients with KTS, 
although extremely rare, there is a possibility of systemic 
manifestations usually in the form of generalized angioma-
tosis, which requires detailed diagnostic tests in order to 
timely detect any changes in the internal organs and start 
with treatment and prevention of complications, which 
can be fatal for a patient.
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КРАТАК САДРЖАЈ
Увод Кли  пел–Тре  но  не  ов (Klip pel–Tréna u nay) син  дром (КТС) 
је вр  ло рет  ка уро  ђе  на ано  ма  ли  ја крв  них су  до  ва ко  ју од  ли-
ку  је сле  де  ће кли  нич  ко трој  ство: про  ши  ре  не по  вр  шин  ске 
ве  не, мал  фор  ма  ци  је ка  пи  ла  ра ко  же и обич  но јед  но  стра  на 
хи  пер  тро  фи  ја ко  шта  ног и ме  ког тки  ва екс  тре  ми  те  та (нај-
че  шће на до  њим екс  тре  ми  те  ти  ма). Че  сто је пра  ћен ви  сце-
рал  ним ма  ни  фе  ста  ци  ја  ма, а са  мо рет  ко је удру  жен са спле-
но  ме  га  ли  јом.
При  каз бо  ле  сни  ка Бо  ле  сни  ца ста  ра 30 го  ди  на ја  ви  ла се 
на Кли  ни  ку за хи  рур  ги  ју због по  вре  ме  них бо  ло  ва у ле  вом 
хи  по  хон  дри  ју  му тр  бу  ха. По  ста  вље  на је ди  јаг  но  за КТС удру-
же  ног са спле  но  ме  га  ли  јом, на  кон че  га је ура  ђе  на спле  нек-
то  ми  ја. Ма  кро  скоп  ски и ми  кро  скоп  ски пре  глед сле  зи  не 
ука  за  ли су на ту  мор ва  ску  лар  ног по  ре  кла, на ком  би  на  ци  ју 
лим  фан  ги  о  ма и хе  ман  ги  о  ма.
За  кљу  чак Ди  јаг  но  сти  ко  ван КТС зах  те  ва де  таљ  на кли  нич  ка 
ис  пи  ти  ва  ња болесника због мо  гућ  но  сти по  сто  ја  ња ви  сце-
рал  них ма  ни  фе  ста  ци  ја. Уко  ли  ко по  сто  ји спле  но  ме  га  ли  ја, иако 
је она нај  че  шће бе  ниг  не при  ро  де, спле  нек  то  ми  ја се обич  но 
вр  ши да убла  жи пра  те  ће симп  то  ме ко  ји на  ста  ју услед уве  ћа-
ња ор  га  на и ком  пре  си  је, да спре  чи руп  ту  ру и по  сле  дич  но 
кр  ва  ре  ње ка  да је ва  ску  лар  ни ту  мор сле  зи  не ве  ли  ких ди  мен-
зи  ја, те да би се из  бе  гла мо  гућ  ност ма  лиг  не тран  сфор  ма  ци  је.
Кључ  не ре  чи: Кли  пел–Тре  но  не  ов син  дром; спле  но  ме  га  ли-
ја; хе  ман  ги  ом; лим  фан  ги  ом
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